We are live on
!
Find out more
Agios Pharmaceuticals
AGIO
AGIO
237 hedge funds and large institutions have $1.67B invested in Agios Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 65 funds opening new positions, 79 increasing their positions, 70 reducing their positions, and 44 closing their positions.
New
Increased
Maintained
Reduced
Closed
191% more call options, than puts
Call options by funds: $133M | Put options by funds: $45.6M
48% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 44
13% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 70
8% more funds holding
Funds holding: 220 → 237 (+17)
4.24% less ownership
Funds ownership: 109.29% → 105.05% (-4.2%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
35% less capital invested
Capital invested by funds: $2.55B → $1.67B (-$879M)
Holders
237
Holders Change
+17
Holders Change %
+7.73%
% of All Funds
2.88%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
65
Increased
79
Reduced
70
Closed
44
Calls
$133M
Puts
$45.6M
Net Calls
+$87.2M
Net Calls Change
+$80.1M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$79.7M |
| 2 |
D.E. Shaw & Co
New York
|
+$51.6M |
| 3 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$45.7M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$40.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$30.1M |
Top Sellers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$149M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
-$107M |
| 3 |
CC
Commodore Capital
New York
|
-$93.9M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$78.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$65.7M |